当前位置: X-MOL 学术Nat. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Benefit Corporation: a path to affordable gene therapies?
Nature Medicine ( IF 82.9 ) Pub Date : 2019-12-01 , DOI: 10.1038/s41591-019-0676-z
Alain Fischer 1 , Mathias Dewatripont 2, 3 , Michel Goldman 3
Affiliation  

With the growing number of efficient gene therapies on the market, now is the time to take actions to ensure reasonable pricing of gene therapy products. Among these, we propose to incentivize gene therapy companies to adopt a status that translates their corporate social responsibility into concrete commitments.

中文翻译:

Benefit Corporation:一条通往负担得起的基因疗法的道路?

随着市场上越来越多的高效基因疗法,现在是采取行动确保基因疗法产品合理定价的时候了。其中,我们建议激励基因治疗公司采取将其企业社会责任转化为具体承诺的地位。
更新日期:2019-11-26
down
wechat
bug